PortfoliosLab logoPortfoliosLab logo
AMRX vs. SPY
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

AMRX vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amneal Pharmaceuticals, Inc. (AMRX) and State Street SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AMRX achieves a 27.86% return, which is significantly higher than SPY's 9.74% return. Over the past 10 years, AMRX has underperformed SPY with an annualized return of -5.79%, while SPY has yielded a comparatively higher 15.70% annualized return.


AMRX

1D
-0.62%
1M
29.71%
YTD
27.86%
6M
25.66%
1Y
106.01%
3Y*
77.51%
5Y*
25.09%
10Y*
-5.79%

SPY

1D
-0.31%
1M
0.09%
YTD
9.74%
6M
9.27%
1Y
26.65%
3Y*
21.27%
5Y*
13.51%
10Y*
15.70%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AMRX vs. SPY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AMRX
Amneal Pharmaceuticals, Inc.
27.86%59.09%30.48%205.03%-58.46%4.81%-5.19%-64.38%-18.74%25.66%
SPY
State Street SPDR S&P 500 ETF
9.74%17.72%24.89%26.18%-18.18%28.73%18.33%31.22%-4.57%21.71%

Correlation

The correlation between AMRX and SPY is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.32

Correlation (3Y)
Calculated over the trailing 3-year period

0.38

Correlation (5Y)
Calculated over the trailing 5-year period

0.39

Correlation (10Y)
Calculated over the trailing 10-year period

0.35

Correlation (All Time)
Calculated using the full available price history since Jan 15, 2009

0.38

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AMRX vs. SPY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMRX
AMRX Risk / Return Rank: 9393
Overall Rank
AMRX Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
AMRX Sortino Ratio Rank: 9595
Sortino Ratio Rank
AMRX Omega Ratio Rank: 9494
Omega Ratio Rank
AMRX Calmar Ratio Rank: 9191
Calmar Ratio Rank
AMRX Martin Ratio Rank: 9090
Martin Ratio Rank

SPY
SPY Risk / Return Rank: 6868
Overall Rank
SPY Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
SPY Sortino Ratio Rank: 6666
Sortino Ratio Rank
SPY Omega Ratio Rank: 6868
Omega Ratio Rank
SPY Calmar Ratio Rank: 6363
Calmar Ratio Rank
SPY Martin Ratio Rank: 7474
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AMRX vs. SPY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amneal Pharmaceuticals, Inc. (AMRX) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AMRXSPYDifference
Sharpe ratioReturn per unit of total volatility

+1.16

Sortino ratioReturn per unit of downside risk

+1.09

Omega ratioGain probability vs. loss probability

1.50

1.39

+0.11

Calmar ratioReturn relative to maximum drawdown

4.79

3.01

+1.78

Martin ratioReturn relative to average drawdown

11.85

13.54

-1.69

AMRX vs. SPY - Sharpe Ratio Comparison

The current AMRX Sharpe Ratio is 3.32, which is higher than the SPY Sharpe Ratio of 2.16. The chart below compares the historical Sharpe Ratios of AMRX and SPY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AMRX vs. SPY - Drawdown Comparison

The maximum AMRX drawdown since its inception was -97.52%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for AMRX and SPY.


Loading charts...

Drawdown Indicators


AMRXSPYDifference

Max Drawdown

Largest peak-to-trough decline

-97.52%

-55.19%

-42.33%

Max Drawdown (1Y)

Largest decline over 1 year

-22.25%

-8.88%

-13.37%

Max Drawdown (3Y)

Largest decline over 3 years

-26.80%

-18.76%

-8.04%

Max Drawdown (5Y)

Largest decline over 5 years

-78.29%

-24.50%

-53.79%

Max Drawdown (10Y)

Largest decline over 10 years

-95.98%

-33.72%

-62.26%

Current Drawdown

Current decline from peak

-68.60%

-1.75%

-66.85%

Average Drawdown

Average peak-to-trough decline

-54.34%

-9.04%

-45.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.98%

1.97%

+7.01%

Volatility

AMRX vs. SPY - Volatility Comparison

Amneal Pharmaceuticals, Inc. (AMRX) has a higher volatility of 11.49% compared to State Street SPDR S&P 500 ETF (SPY) at 4.64%. This indicates that AMRX's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AMRXSPYDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.49%

4.64%

+6.85%

Volatility (6M)

Calculated over the trailing 6-month period

24.31%

9.75%

+14.56%

Volatility (1Y)

Calculated over the trailing 1-year period

32.20%

12.43%

+19.77%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

50.98%

17.14%

+33.84%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

65.26%

17.99%

+47.27%

Dividends

AMRX vs. SPY - Dividend Comparison

AMRX has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.01%.


PositionTTM20252024202320222021202020192018201720162015
AMRX
Amneal Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
State Street SPDR S&P 500 ETF
1.01%1.07%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%

Frequently Asked Questions


AMRX and SPY have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AMRX has higher volatility (11.49%) compared to SPY (4.64%). In terms of maximum drawdown, AMRX dropped -97.52% vs SPY's -55.19%.

AMRX currently has the higher Sharpe Ratio (3.32 vs 2.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AMRX and SPY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer